Intravenous vs. epidural analgesia to reduce the incidence of gastrointestinal complications after elective pancreatoduodenectomy
- Conditions
- C25Malignant neoplasm of pancreas
- Registration Number
- DRKS00007784
- Lead Sponsor
- niversitätsklinikum Heidelberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 371
Patients scheduled for elective pancreatoduodenectomy
- Age = 18 years
- Ability of subject to understand character and individual consequences of the clinical trial
- Written informed consent
- Chronic pancreatitis
- Severe COPD (Stage III according to GOLD criteria)
- American Society of Anesthesiologists (ASA) physical status classification = IV
- Patients with chronic pain syndrome due to any reason
- Presence of contraindication(s) to the use of patient-controlled intravenous analgesia or epidural analgesia
- Participation in another intervention-trial with interference of intervention and outcome of this study
- Language problems
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Combined endpoint of gastrointestinal complications (Delayed gastric emptying, pancreatic fistula, biliary leak, gastrointestinal bleeding, postoperative ileus) until postoperative day 30.<br>
- Secondary Outcome Measures
Name Time Method - Delayed gastric emptying<br>- Pancreatic fistula<br>- Biliary leak<br>- Gastrointestinal bleeding<br>- Postoperative ileus<br>- Combined endpoint of infectious complications (pneumonia, urinary tract infection, wound infection intraabdominal abscess, sepsis)<br>- Hospital stay / ICU stay / readmission until postoperative day 30<br>- Mortality <br>- Morbidity until postoperative day 30<br>- Frequency of blood transfusions<br>- Amount of given vasopressors during operation<br>- Pain control with numeric rating scale (NRS)<br>- Amount of given fluids<br>- Weight over time/weight changes<br>- SAE